Cargando…

A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India

Introduction: Neurofibromatosis type 1 (NF1) is an inherited neuroectodermal abnormality with multisystem effects, which can have heavy psychological and physical burdens, especially in countries like India, wherein skin disease is significantly stigmatized. This study was performed to understand th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahajan, Aditi, Patvekar, Milind, Lote, Samruddhi, Deora, Mahendra Singh, Poulose, Divya, Gogineni, Jaya Madhurya, Panikar, Krish, Chaklader, Biswajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940560/
https://www.ncbi.nlm.nih.gov/pubmed/35371718
http://dx.doi.org/10.7759/cureus.22376
_version_ 1784672951701864448
author Mahajan, Aditi
Patvekar, Milind
Lote, Samruddhi
Deora, Mahendra Singh
Poulose, Divya
Gogineni, Jaya Madhurya
Panikar, Krish
Chaklader, Biswajit
author_facet Mahajan, Aditi
Patvekar, Milind
Lote, Samruddhi
Deora, Mahendra Singh
Poulose, Divya
Gogineni, Jaya Madhurya
Panikar, Krish
Chaklader, Biswajit
author_sort Mahajan, Aditi
collection PubMed
description Introduction: Neurofibromatosis type 1 (NF1) is an inherited neuroectodermal abnormality with multisystem effects, which can have heavy psychological and physical burdens, especially in countries like India, wherein skin disease is significantly stigmatized. This study was performed to understand the clinical and epidemiological trends of NF1 at a tertiary care center in India and evaluate the association between clinical severity and quality of life in these patients. Methods: We conducted a cross-sectional study of 40 patients with NF1 over a period of two years at a tertiary hospital in western India. After obtaining consent, demographic and clinical information was collected from the patients and recorded in a pre-designed proforma. Quality of life was assessed by a validated Dermatology Life Quality Index (DLQI) questionnaire in languages understood by the patients and subsequently analyzed. Results: This study included 40 patients at a mean age of 28.6 years, with a slight male predominance. The most frequently occurring lesions were café-au-lait macules, followed by neurofibromas and intertriginous freckling. The mean DLQI score was 12.35, implying a large effect on most patients' lives. Questions related to self-consciousness, embarrassment, and the influence of skin lesions on clothing choices had the highest scores, indicating a significant effect on social perception. Conclusion: NF1 has a profound impact on a patient’s quality of life, as evidenced by the high DLQI scores in our patient cohort. The early identification and management of such patients can help prevent further deterioration of their quality of life.
format Online
Article
Text
id pubmed-8940560
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-89405602022-03-31 A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India Mahajan, Aditi Patvekar, Milind Lote, Samruddhi Deora, Mahendra Singh Poulose, Divya Gogineni, Jaya Madhurya Panikar, Krish Chaklader, Biswajit Cureus Dermatology Introduction: Neurofibromatosis type 1 (NF1) is an inherited neuroectodermal abnormality with multisystem effects, which can have heavy psychological and physical burdens, especially in countries like India, wherein skin disease is significantly stigmatized. This study was performed to understand the clinical and epidemiological trends of NF1 at a tertiary care center in India and evaluate the association between clinical severity and quality of life in these patients. Methods: We conducted a cross-sectional study of 40 patients with NF1 over a period of two years at a tertiary hospital in western India. After obtaining consent, demographic and clinical information was collected from the patients and recorded in a pre-designed proforma. Quality of life was assessed by a validated Dermatology Life Quality Index (DLQI) questionnaire in languages understood by the patients and subsequently analyzed. Results: This study included 40 patients at a mean age of 28.6 years, with a slight male predominance. The most frequently occurring lesions were café-au-lait macules, followed by neurofibromas and intertriginous freckling. The mean DLQI score was 12.35, implying a large effect on most patients' lives. Questions related to self-consciousness, embarrassment, and the influence of skin lesions on clothing choices had the highest scores, indicating a significant effect on social perception. Conclusion: NF1 has a profound impact on a patient’s quality of life, as evidenced by the high DLQI scores in our patient cohort. The early identification and management of such patients can help prevent further deterioration of their quality of life. Cureus 2022-02-19 /pmc/articles/PMC8940560/ /pubmed/35371718 http://dx.doi.org/10.7759/cureus.22376 Text en Copyright © 2022, Mahajan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Mahajan, Aditi
Patvekar, Milind
Lote, Samruddhi
Deora, Mahendra Singh
Poulose, Divya
Gogineni, Jaya Madhurya
Panikar, Krish
Chaklader, Biswajit
A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India
title A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India
title_full A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India
title_fullStr A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India
title_full_unstemmed A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India
title_short A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India
title_sort clinico-epidemiological study of neurofibromatosis type 1 and its relation to quality of life: a cross-sectional study from india
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940560/
https://www.ncbi.nlm.nih.gov/pubmed/35371718
http://dx.doi.org/10.7759/cureus.22376
work_keys_str_mv AT mahajanaditi aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT patvekarmilind aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT lotesamruddhi aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT deoramahendrasingh aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT poulosedivya aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT goginenijayamadhurya aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT panikarkrish aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT chakladerbiswajit aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT mahajanaditi clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT patvekarmilind clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT lotesamruddhi clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT deoramahendrasingh clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT poulosedivya clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT goginenijayamadhurya clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT panikarkrish clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia
AT chakladerbiswajit clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia